You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The added funds will be used by Tangen to develop a molecular diagnostic platform to detect anthrax in the bloodstream and develop infectious disease tests.
The company's revenue growth was driven by increasing sales of its ePlex molecular diagnostics analyzer, which now has a SARS-CoV-2 test.
Questions swirl regarding whether Alex Azar, the secretary of the Department of Health and Human Services, may soon be out of a job, the Wall Street Journal reports.
Former BARDA chief Rick Bright tells the New York Times he was forced out because he pushed for strict testing of a coronavirus treatment touted by President Donald Trump.
Stat News reports Rick Bright is no longer the head of the Biomedical Advanced Research and Development Authority.
The funding will support validation of an assay for both manual and high-throughput automated workflows.
Under the Public Readiness and Emergency Preparedness Act, pharmacists qualify as "covered persons" to administer SARS-CoV-2 tests.
The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.
The Aries SARS-CoV-2 assay provides results in approximately two hours and can be run on Luminex's sample-to-answer Aries Systems.
The test is the fourth COVID-19 molecular diagnostic to be awarded funding from BARDA. Others include Hologic, Qiagen, and DiaSorin Molecular.
Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.
Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.
Science reports that a Dutch research funding agency is combating a ransomware attack.
In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.